Results 221 to 230 of about 576,280 (398)
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo +11 more
wiley +1 more source
Two Cases of Allergic Contact Dermatitis Caused by Coco Betaine in Clobetasol Propionate Shampoo. [PDF]
Iijima S +4 more
europepmc +1 more source
Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino +3 more
wiley +1 more source
Atopic dermatitis and fecundity: a Danish National Birth Cohort study. [PDF]
Kjersgaard CL +7 more
europepmc +1 more source
Kampo Medicines for Mite Antigen‐Induced Allergic Dermatitis in NC/Nga Mice [PDF]
Xiu Kun Gao +5 more
openalex +1 more source
Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic
ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip +5 more
wiley +1 more source
Generalized Dermatitis Caused by <i>Staphylococcus aureus</i> in the European Bison. [PDF]
Boneva-Marutsova B, Marutsov P.
europepmc +1 more source
Efficacy of Colloidal Oatmeal-shampoo on Pruritic Canine Dermatitis.
Takeo MINAMI, Yukitaka Okada
openalex +2 more sources

